Kunming Baker Norton Pharmaceutical

Kunming Baker Norton Pharmaceutical (KBN) is a leading Chinese pharmaceutical company established in 1992 as a joint venture between Kunming Pharmaceutical Group and Baker Norton Pharmaceuticals. The company specializes in the research, development, and manufacturing of high-quality generic and specialty medicines across several therapeutic areas, including pediatrics, respiratory, and anti-infectives. KBN is recognized for being one of the first pharmaceutical enterprises in China to receive GMP certification and has maintained a strong reputation for international quality standards. Its product portfolio includes well-known brands such as Amoxicillin and Beclomethasone, serving a vast network of hospitals and pharmacies throughout China.